一个广泛可通用的稳定策略,用于sarbecovirus融合机器疫苗
Jimin Lee1, Cameron Stewart1, Alexandra Schaefer2
1Department of Biochemistry, University of Washington, Seattle, Washington, USA.
bioRxiv : the preprint server for biology
|January 3, 2024
概括
针对SARS-CoV-2保存的S2亚单元的新疫苗提供了针对不断演变的变种的广泛保护. 这种方法通过将抗体反应集中在病毒的融合机器上来克服免疫逃避.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 蛋白质工程是指蛋白质的工程.
背景情况:
- SARS-CoV-2 持续演变,改变尖端蛋白的抗原性,降低疫苗/抗体的有效性.
- 目前的疫苗和疗法向尖端蛋白的可变区域,导致免疫逃逸.
- 需要一个保存的目标来克服病毒的进化和扩大保护.
结论:
- 一种预注射稳定S2三分体疫苗会产生交叉反应的中和抗体.
- 接种疫苗的小鼠显示对SARS-CoV-2 XBB.1.5挑战有保护作用.
- 这一战略为下一代沙贝科病毒疫苗提供了一个有希望的原则证明.
相关概念视频
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


